» Articles » PMID: 33426628

Attenuation of the Induction of TLRs 2 and 4 Mitigates Inflammation and Promotes Neurological Recovery After Focal Cerebral Ischemia

Abstract

The intense inflammatory response triggered in the brain after focal cerebral ischemia is detrimental. Recently, we showed that the suppression of toll-like receptors (TLRs) 2 and 4 attenuates infarct size and reduces the expression of pro-inflammatory cytokines in the ischemic brain. In this study, we further examined the effect of unsuppressed induction of TLRs 2 and 4 on the expression of its downstream signaling molecules and pro-inflammatory cytokines 1 week after reperfusion. The primary purpose of this study was to investigate the effect of simultaneous knockdown of TLRs 2 and 4 on M1/M2 microglial polarization dynamics and post-stroke neurological deficits and the recovery. Transient focal cerebral ischemia was induced in young adult male Sprague-Dawley rats by the middle cerebral artery occlusion (MCAO) procedure using a monofilament suture. Appropriate cohorts of rats were treated with a nanoparticle formulation of TLR2shRNA and TLR4shRNA (T2sh+T4sh) expressing plasmids (1 mg/kg each of T2sh and T4sh) or scrambled sequence inserted vector (vehicle control) expressing plasmids (2 mg/kg) intravenously via tail vein immediately after reperfusion. Animals from various cohorts were euthanized during reperfusion, and the ischemic brain tissue was isolated and utilized for PCR followed by agarose gel electrophoresis, real-time PCR, immunoblot, and immunofluorescence analysis. Appropriate groups were subjected to a battery of standard neurological tests at regular intervals until 14 days after reperfusion. The increased expression of both TLRs 2 and 4 and their downstream signaling molecules including the pro-inflammatory cytokines was observed even at 1-week after reperfusion. T2sh+T4sh treatment immediately after reperfusion attenuated the post-ischemic inflammation, preserved the motor function, and promoted recovery of the sensory and motor functions. We conclude that the post-ischemic induction of TLRs 2 and 4 persists for at least 7 days after reperfusion, contributes to the severity of acute inflammation, and impedes neurological recovery. Unlike previous studies in TLRs 2 or 4 knockout models, results of this study in a pharmacologically relevant preclinical rodent stroke model have translational significance.

Citing Articles

The paradox of tPA in ischemic stroke: tPA knockdown following recanalization improves functional and histological outcomes.

Challa S, Nalamolu K, Fornal C, Baker I, Mohandass A, Mada S Exp Neurol. 2024; 374:114727.

PMID: 38360257 PMC: 10986679. DOI: 10.1016/j.expneurol.2024.114727.


Ethanol Induces Neuroinflammation in a Chronic Plus Binge Mouse Model of Alcohol Use Disorder via TLR4 and MyD88-Dependent Signaling.

Holloway K, Douglas J, Rafferty T, Kane C, Drew P Cells. 2023; 12(16).

PMID: 37626919 PMC: 10453365. DOI: 10.3390/cells12162109.


Nanodrugs for the Treatment of Ischemic Stroke: A Systematic Review.

Ruscu M, Cercel A, Kilic E, Catalin B, Gresita A, Hermann D Int J Mol Sci. 2023; 24(13).

PMID: 37445979 PMC: 10341504. DOI: 10.3390/ijms241310802.


A comprehensive review of stroke-related signaling pathways and treatment in western medicine and traditional Chinese medicine.

Chen B, Jin W Front Neurosci. 2023; 17:1200061.

PMID: 37351420 PMC: 10282194. DOI: 10.3389/fnins.2023.1200061.


Implications of MMP-12 in the pathophysiology of ischaemic stroke.

Veeravalli K Stroke Vasc Neurol. 2023; 9(2):97-107.

PMID: 37336584 PMC: 11103161. DOI: 10.1136/svn-2023-002363.


References
1.
Barone F, Feuerstein G . Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab. 1999; 19(8):819-34. DOI: 10.1097/00004647-199908000-00001. View

2.
Chamorro A, Hallenbeck J . The harms and benefits of inflammatory and immune responses in vascular disease. Stroke. 2006; 37(2):291-3. PMC: 1852506. DOI: 10.1161/01.STR.0000200561.69611.f8. View

3.
Petrovic-Djergovic D, Goonewardena S, Pinsky D . Inflammatory Disequilibrium in Stroke. Circ Res. 2016; 119(1):142-58. PMC: 5138050. DOI: 10.1161/CIRCRESAHA.116.308022. View

4.
Jin R, Liu L, Zhang S, Nanda A, Li G . Role of inflammation and its mediators in acute ischemic stroke. J Cardiovasc Transl Res. 2013; 6(5):834-51. PMC: 3829610. DOI: 10.1007/s12265-013-9508-6. View

5.
Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T . Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol. 2002; 168(9):4531-7. DOI: 10.4049/jimmunol.168.9.4531. View